AI-Driven Precision Medicine: Comprehensive Applications in Disease Prediction, Personalized Treatment, and Drug Discovery

Kexin Yu , Jun Jiang , Zhigang Jiang , Jiangjiao Liu , Roy Rillera Marzo

Artificial Intelligence and Medicine ›› 2025, Vol. 1 ›› Issue (1) : 18 -27.

PDF (369KB)
Artificial Intelligence and Medicine ›› 2025, Vol. 1 ›› Issue (1) :18 -27. DOI: 10.37420/j.jaim.2025.003
Articles
research-article
AI-Driven Precision Medicine: Comprehensive Applications in Disease Prediction, Personalized Treatment, and Drug Discovery
Author information +
History +
PDF (369KB)

Abstract

This review explores AI’s transformative role in precision medicine, focusing on disease prediction, personalized treatment, and drug discovery. In disease prediction, AI uses EHRs, imaging, and multi-omics data to stratify risks: XGBoost outperforms traditional models in CVD risk prediction; deep learning enhances early cancer detection (e.g., oral cancer via histopathology images); multi-omics integration aids neurodegenerative disease forecasting; and GCNs predict infectious outbreaks via real-time keyword analysis. For personalized treatment, AI tailors strategies: it analyzes genomic profiles to guide cancer therapy (e.g., identifying HER2 activation in CDK4/6i-resistant breast cancer); PK/PD modeling optimizes drug dosages (e.g., rituximab in nephropathy); it refines clinical trial patient selection (e.g., ASM choice for epilepsy); improves mental health diagnosis/treatment; and designs personalized stroke rehabilitation via wearable sensor data. In drug discovery, AI accelerates the pipeline: it identifies targets (e.g., SSO binding sites in triple-negative breast cancer); virtual screening (e.g., DeepDock for JAK3 inhibitors) and de novo design (e.g., CLMs for PI3Kγ inhibitors) find lead compounds; MIFAM-DTI predicts drug-target interactions; AI optimizes clinical trial design; and it enables drug repurposing (e.g., identifying fibrosis-related drugs via EHRs). Key challenges include data privacy (addressed via blockchain/SecPri-BGMPOP), algorithmic bias (needing diverse datasets), explainable AI (critical for CDSS trust), and multi-omics integration. AI-driven precision medicine promises proactive, personalized healthcare, requiring collaboration across stakeholders for ethical implementation.

Keywords

artificial intelligence / disease prediction / personalized treatment / drug discovery

Cite this article

Download citation ▾
Kexin Yu, Jun Jiang, Zhigang Jiang, Jiangjiao Liu, Roy Rillera Marzo. AI-Driven Precision Medicine: Comprehensive Applications in Disease Prediction, Personalized Treatment, and Drug Discovery. Artificial Intelligence and Medicine, 2025, 1(1): 18-27 DOI:10.37420/j.jaim.2025.003

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Dr. R. Deepa , Vijaya Bhaskar Sadu , P. C , Dr. A. Sivasamy , Early prediction of cardiovascular disease using machine learning: Unveiling risk factors from health records, AIP Advances, 2024.

[2]

Chaiquan Li , Xiaofei Liu , P. Shen , Yexiang Sun , T. Zhou , Weiye Chen , Qi Chen , Hongbo Lin , Xun Tang , P. Gao , Improving cardiovascular risk prediction through machine learning modelling of irregularly repeated electronic health records, European Heart Journal. Digital Health, 2023, 5, 30-40.

[3]

Fang He , John H Page , Jesisca Tandi , Abhijit Ghosh , C. Liman , J. Sarkar , K. Yeo , Major Adverse Cardiovascular Event Risk Prediction in Asian Patients After Myocardial Infarction: A Novel, Dynamic, Machine—learning Approach, Journal of Asian Pacific Society of Cardiology, 2023.

[4]

Danxi Zheng , Xiujing He , Jing Jing , Overview of Artificial Intelligence in Breast Cancer Medical Imaging, Journal of Clinical Medicine, 2023, 12.

[5]

A. Bai , M. Si , P. Xue , Yimin Qu , Yu Jiang , Artificial intelligence performance in detecting lymphoma from medical imaging: a systematic review and meta—analysis, BMC Medical Informatics and Decision Making, 2024, 24.

[6]

R. K. Sahoo , K. Sahoo , G. Dash , Gunjan Kumar , Santos Kumar Baliarsingh , Bhuputra Panda , Sanghamitra Pati , Diagnostic performance of artificial intelligence in detecting oral potentially malignant disorders and oral cancer using medical diagnostic imaging: a systematic review and meta—analysis, Frontiers in Oral Health, 2024, 5.

[7]

Andrea Termine , Carlo Fabrizio , C. Strafella , V. Caputo , L. Petrosini , C. Caltagirone , E. Giardina , R. Cascella , Multi—Layer Picture of Neurodegenerative Diseases: Lessons from the Use of Big Data through Artificial Intelligence, Journal of Personalized Medicine, 2021, 11.

[8]

C. Baciu , Cherry Xu , Mouaid Alim , Khairunnadiya Prayitno , M. Bhat , Artificial intelligence applied to omics data in liver diseases: Enhancing clinical predictions, Frontiers in Artificial Intelligence, 2022, 5.

[9]

Ania Syrowatka , Masha Kuznetsova , Ava Alsubai , Adam L. Beckman , P. Bain , K. Craig , Jianying Hu , G. Jackson , K. Rhee , D. Bates , Leveraging artificial intelligence for pandemic preparedness and response: a scoping review to identify key use cases, NPJ Digital Medicine, 2021, 4.

[10]

Ligui Wang , Yuqi Liu , Hui Chen , S. Qiu , Yonghong Liu , Mingjuan Yang , X. Du , Zhenjun Li , Rongzhang Hao , Huaiyu Tian , Hongbin Song , Search—engine—based surveillance using artificial intelligence for early detection of coronavirus disease outbreak, Journal of Big Data, 2023, 10, 1-12.

[11]

Backyard flock sampling and artificial intelligence: A dual strategy for early detection of Avian Influenza and Newcastle Disease, German Journal of Veterinary Research, 2024.

[12]

Jorge Gómez Tejeda Zañudo , R. Barroso—Sousa , Esha Jain , Qing Jin , Tianyu Li , Jorge E. Buendia—Buendia , A. Pereslete , Daniel L. Abravanel , Arlindo R Ferreira , E. Wrabel , K. Helvie , Melissa E Hughes , Ann H. Partridge , Beth Overmoyer , N. Lin , N. Tayob , S. Tolaney , N. Wagle , Exemestane plus everolimus and palbociclib in metastatic breast cancer: clinical response and genomic/transcriptomic determinants of resistance in a phase I/II trial, Nature Communications, 2024, 15.

[13]

Laura Boucai , Mahesh Saqcena , F. Kuo , R. Grewal , N. Socci , J. Knauf , Gnana P. Krishnamoorthy , Mabel Ryder , A. Ho , R. Ghossein , L. Morris , V. Seshan , J. Fagin , Genomic and transcriptomic characteristics of metastatic thyroid cancers with exceptional responses to radioactive iodine therapy., Clinical cancer research : an official journal of the American Association for Cancer Research, 2023.

[14]

Hao Liang , Zhenling Deng , Shu Niu , Weijie Kong , Yang Liu , Song Wang , Haiyan Li , Yue Wang , Danxia Zheng , Dongyang Liu , Dosing optimization of rituximab for primary membranous nephropathy by population pharmacokinetic and pharmacodynamic study, Frontiers in Pharmacology, 2024, 15.

[15]

Chao—Yang Chen , M. Xie , J. Gong , Ning Yu , Ran Wei , Lili Lei , Siru Zhao , Ruoming Li , Xiu Dong , Xiang—lin Zhang , Ying Zhou , Shuangling Li , Yi—min Cui , Population pharmacokinetic analysis and dosing regimen optimization of teicoplanin in critically ill patients with sepsis, Frontiers in Pharmacology, 2023, 14.

[16]

Claudio Carini , A. Seyhan , Tribulations and future opportunities for artificial intelligence in precision medicine, Journal of Translational Medicine, 2024, 22.

[17]

Charlene L. Gunasekera , J. Sirven , A. Feyissa , The evolution of antiseizure medication therapy selection in adults: Is artificial intelligence —assisted antiseizure medication selection ready for prime time?, Journal of Central Nervous System Disease, 2023, 15.

[18]

S. Hanassab , A. Abbara , Arthur C. Yeung , M. Voliotis , K. Tsaneva—Atanasova , T. Kelsey , Geoffrey H. Trew , Scott M. Nelson , T. Heinis , W. Dhillo , The prospect of artificial intelligence to personalize assisted reproductive technology, NPJ Digital Medicine, 2024, 7.

[19]

A. Alhuwaydi , Exploring the Role of Artificial Intelligence in Mental Healthcare: Current Trends and Future Directions — A Narrative Review for a Comprehensive Insight, Risk Management and Healthcare Policy, 2024, 17, 1339-1348.

[20]

Bin Wu , Real Time Monitoring Research on Rehabilitation Effect of Artificial Intelligence Wearable Equipment on Track and Field Athletes, EAI Endorsed Trans. Pervasive Health Technol., 2024, 10.

[21]

Iqram Hussain , Rafsan Jany , Interpreting Stroke—Impaired Electromyography Patterns through Explainable Artificial Intelligence, Sensors (Basel, Switzerland), 2024, 24.

[22]

Jyotismita Chaki , Marcin Woźniak , Deep Learning and Artificial Intelligence in Action (2019—2023): A Review on Brain Stroke Detection, Diagnosis, and Intelligent Post—Stroke Rehabilitation Management, IEEE Access, 2024, 12, 52161-52181.

[23]

Purnendu B. Acharjee 1, Bhupaesh Ghai , Muniyandy Elangovan , S. Bhuvaneshwari , Ravi Rastogi , P. Rajkumar , Exploring AI—driven approaches to drug discovery and development, The Scientific Temper, 2023.

[24]

Yujie You , Xin Lai , Ying Pan , Huiru Zheng , J. Vera , Suran Liu , Senyi Deng , Le Zhang , Artificial intelligence in cancer target identification and drug discovery, Signal Transduction and Targeted Therapy, 2022, 7.

[25]

Alyssa D Fronk , M. Manzanares , P. Zheng , Adam Geier , K. Anderson , Shaleigh Stanton , Hasan Zumrut , Sakshi Gera , Robin Munch , Vanessa Frederick , Priyanka Dhingra , G. Arun , Martin Akerman , Development and validation of AI/ML derived splice—switching oligonucleotides, Molecular Systems Biology, 2024, 20, 676-701.

[26]

Mohammad Ali Mahjoub , Zahra Sheikholislam , Artificial Intelligence in Drug Discovery and Delivery: Advancements and Applications, Journal of Biomedical Research&Environmental Sciences, 2023.

[27]

Pravin Tajane , N. Kayande , Avinash Bhosale , Sumit Deore , Harshal Tare , Design and Discovery of Silmitasertib—based Drugs as a Potential Casein Kinase II Inhibitor for Cholangiocarcinoma through Hybrid In—silico Ligand—Based Virtual Screening with Molecular Docking Method, INTERNATIONAL JOURNAL OF DRUG DELIVERY TECHNOLOGY, 2023.

[28]

Juying Wei , Youlu Pan , Zheyuan Shen , Liteng Shen , Lei Xu , Wenjuan Yu , Wenhai Huang , A hybrid energy—based and AI—based screening approach for the discovery of novel inhibitors of JAK3, Frontiers in Medicine, 2023, 10.

[29]

Michael Moret , Irene Pachon Angona , Leandro Cotos , Shen Yan , Kenneth Atz , Cyrill Brunner , M. Baumgartner , F. Grisoni , G. Schneider , Leveraging molecular structure and bioactivity with chemical language models for de novo drug design, Nature Communications, 2023, 14.

[30]

Tilman Hinnerichs , R. Hoehndorf , DTI—Voodoo: machine learning over interaction networks and ontology—based background knowledge predicts drug—target interactions, Bioinformatics, 2021, 37, 4835-4843.

[31]

Jianwei Li , Lianwei Sun , Lingbo Liu , Ziyu Li , MIFAM—DTI: a drug—target interactions predicting model based on multi—source information fusion and attention mechanism, Frontiers in Genetics, 2024, 15.

[32]

Omega John Unogwu , Mabel Ike , Opkanachi Omatule Joktan , Employing Artificial Intelligence Methods in Drug Development: A New Era in Medicine, Mesopotamian Journal of Artificial Intelligence in Healthcare, 2023.

[33]

Emmanuel Chamorey , Jocelyn Gal , B. Mograbi , Gerard Milano , Critical Appraisal and Future Challenges of Artificial Intelligence and Anticancer Drug Development, Pharmaceuticals, 2024, 17.

[34]

Priya Vij , Pharma in The Digital Era: The Role of Artificial Intelligence in Drug Development, Communications on Applied Nonlinear Analysis, 2024.

[35]

Ziaurrehman Tanoli , M. Vähä—Koskela , T. Aittokallio , Artificial intelligence, machine learning, and drug repurposing in cancer, Expert Opinion on Drug Discovery, 2021, 16, 977-989.

[36]

Saeed Shakibfar , K. Allin , Tine Jess , Maria Antonietta Barbieri , V. Battini , Eva Simoncic , J. Kirchgesner , Trond Ulven , Maurizio Sessa , Drug Repurposing in Crohn’s Disease Using Danish Real—World Data, Pragmatic and Observational Research, 2024, 15, 17-29.

[37]

Na Ly Tran , Hyerim Kim , Cheol—Hee Shin , Eun Ko , Seung Ja Oh , Artificial intelligence—driven new drug discovery targeting serine/threonine kinase 33 for cancer treatment, Cancer Cell International, 2023, 23.

[38]

A. Challa , Nicole M. Zaleski , Rebecca N. Jerome , R. Lavieri , J. Shirey—Rice , A. Barnado , C. Lindsell , D. Aronoff , L. Crofford , Raymond C. Harris , T. Alp Ikizler , I. Mayer , K. Holroyd , J. Pulley , Human and Machine Intelligence Together Drive Drug Repurposing in Rare Diseases, Frontiers in Genetics, 2021, 12.

[39]

Faiza Tazi , A. Nandakumar , J. Dykstra , Prashanth Rajivan , Sanchari Das , SoK: Analyzing Privacy and Security of Healthcare Data from the User Perspective, ACM Transactions on Computing for Healthcare, 2024, 5, 1-31.

[40]

Preeti Rani , Sonia Verma , S. Yadav , Bipin Kumar Rai , Mahaveer Singh Naruka , Devendra Kumar , Simulation of the Lightweight Blockchain Technique Based on Privacy and Security for Healthcare Data for the Cloud System, Int. J. E Health Medical Commun., 2022, 13, 1-15.

[41]

Moorthi Kuttiyappan , Jothi Prabha Appadurai , B. P. Kavin , Jeeva Selvaraj , Hong—Seng Gan , Wen—Cheng Lai , Big Data Privacy Protection and Security Provisions of the Healthcare SecPri—BGMPOP Method in a Cloud Environment, Mathematics, 2024.

[42]

Emilio Ferrara , Fairness And Bias in Artificial Intelligence: A Brief Survey of Sources, Impacts, And Mitigation Strategies, ArXiv, 2023, abs/2304.07683.

[43]

K. Drukker , Weijie Chen , Judy Gichoya , Nicholas P. Gruszauskas , Jayashree Kalpathy—Cramer , Sanmi Koyejo , Kyle Myers , Rui C. , B. Sahiner , Heather M. Whitney , Zi Zhang , M. Giger , Toward fairness in artificial intelligence for medical image analysis: identification and mitigation of potential biases in the roadmap from data collection to model deployment, Journal of Medical Imaging, 2023, 10.

[44]

Se Young Kim , Daeho Kim , Min Ji Kim , Hyo Jin Ko , O. Jeong , XAI—Based Clinical Decision Support Systems: A Systematic Review, Applied Sciences, 2024.

[45]

J. Amann , Dennis Vetter , S. Blomberg , H. Christensen , M. Coffee , S. Gerke , T. Gilbert , Thilo Hagendorff , Sune Holm , Michelle Livne , Andy Spezzatti , Inga Strümke , R. Zicari , V. Madai , To explain or not to explain?—Artificial intelligence explainability in clinical decision support systems, PLOS Digital Health, 2022, 1.

[46]

Maali Alabdulhafith , Hager Saleh , H. Elmannai , Zainab H. Ali , Shaker El—Sappagh , Jong—Wan Hu , Nora El—Rashidy , A Clinical Decision Support System for Edge/Cloud ICU Readmission Model Based on Particle Swarm Optimization, Ensemble Machine Learning, and Explainable Artificial Intelligence, IEEE Access, 2023, 11, 100604-100621.

[47]

L. Tong , Wenqi Shi , Monica Isgut , Yishan Zhong , Peter Lais , L. Gloster , Jimin Sun , Aniketh Swain , F. Giuste , May D. Wang , Integrating Multi—Omics Data With EHR for Precision Medicine Using Advanced Artificial Intelligence, IEEE Reviews in Biomedical Engineering, 2023, 17, 80-97.

[48]

Mahaly Baptiste , Sarah Shireen Moinuddeen , Courtney Lace Soliz , Hashimul Ehsan , G. Kaneko , Making Sense ofGenetic Information: The Promising Evolution of Clinical Stratification and Precision Oncology Using Machine Learning, Genes, 2021, 12.

[49]

Vyvyenne Michelle Chigboh , Stephane Jean Christophe Zouo , Jeremiah Olamijuwon , Health data analytics for precision medicine: A review of current practices and future directions, International Medical Science Research Journal, 2024.

PDF (369KB)

228

Accesses

0

Citation

Detail

Sections
Recommended

/